Company intelligence / Profile preview

Rocket Science Health

Victoria, British Columbia, Canada

Ownership: Private
Development stage: Other

Overview

Rocket Science Health has developed a precision intranasal drug delivery platform that targets the olfactory region of the brain. This technology is designed to enhance drug delivery for brain-targeted therapies and vaccines. The company has secured a U.S. patent for its device.

Therapeutic areas: Neurology
Modalities: BiologicsLipid nanoparticles (LNPs)PeptidesSmall molecules
Industry: Therapeutic Medical Devices

Partnerships

Kindeva

Beyond the preview

Go deeper on Rocket Science Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rocket Science Health.

Explore the full profile